23. Kyzekove J; Arit J; Aritova M. Is there any relationship between functional dyspepsia and chronic gastritis associated with Heticobacter pylori infection? Hepatogastroenterology 2001 Mar–Apr;48(38):594–602.
24. Mihara M et al. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection: evaluation in a country with high prevalence of atrophic gastritis. Helicobacter 1999 Mar;4(1):40–8.
25. Malfertheiner P Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. Eur J Gastroenterol Hepatol 2001 Aug;13 SuppI 2:S9–11.
26. Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter Pylori infection–the Maastricht 2–200 Consensus Report. Aliment Pharmacol Ther 2002; 16:167–80.
27. Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non–ulcer dyspepsia. BMJ 2000:321:659–64.
28. Sykora J. et al. Symptomatology and specific characteristics of chronic gastritis caused by Helicobacter pylori infection in children in the Czech population– epidemiologic, clinical, endoscopic and histomorphologic study. Cas Lek Cesk 2002 Sep;141(19):615–21.
29. Talley N.J., Zinsmeister A.R., Schleck C.D., et al. Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992:102:1259–68.
30. Talley N.J., Dyspepsia and heartburn: a clinical challenge. Aliment Pharmacol Ther 1997;11(Suppl2):1–8.
31. Talley N.J., Silverstein M, Agreus L, et al. AGA technical review–evaluation of dyspepsia. Gastroenterology 1998:114:582–95.
32. Talley N.J; Meineche–Schmidt V; Pare P; Duckworth M; Raisanen P; Pap A; Kordecki H; Schmid V. Efficacy of omeprazole in functional dyspepsia: double–blind, randomized, placebo–controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998 Nov; 12(11): 1055–65.
33. Talley N.J. Dyspepsia: management guidelines for the millennium Gut 2002:50.
8-09-2015, 19:24